References
- Spencer CM, Faulds D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994;48:794.
- Jiang X, Sha X, Xin H, et al. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials 2011;32:9457.
- Liang L, Lin SW, Dai W, et al. Novel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicity. J Control Release 2012;160:618.
- Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 2009;6:928.
- Lee J, Lee SC, Acharya G, et al. Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm Res 2003;20:1022.
- Lichtman SM, Hurria A, Cirrincione CT, et al. Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol 2012;23:632–8.
- Shan L, Cui S, Du C, et al. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. Biomaterials 2012;33:146.
- Onetto N, Canetta R, Winograd B, et al. Overview of taxol safety. J Natl Cancer Inst Monogr 1993;15:131.
- Wang Y, Hao J, Li Y, et al. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors. Biomaterials 2012;33:4741.
- Koshkina NV, Waldrep JC, Roberts LE, et al. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 2001;7:3258.
- Huh KM, Min HS, Lee SC, et al. A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Control Release 2008;126:122.
- You J, Wang Z, Du Y, et al. Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres. Biomaterials 2013;34:4510.
- Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006;4:61.
- Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377.
- Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751.
- Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615.
- Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653.
- Na JH, Koo H, Lee S, et al. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 2011;32:5252.
- Elstad NL, Fowers KD. OncoGel (ReGel/paclitaxel) – clinical applications for a Novel paclitaxel delivery system. Adv Drug Deliv Rev 2009;61:785.
- Cai S, Thati S, Bagby TR, et al. Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. J Control Release 2010;146:212.
- Al-Abd AM, Hong KY, Song SC, Kuh HJ. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 2010;142:101.
- Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008;37:1473.
- Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Control Release 2008;126:205.
- Lee J, Tan CY, Lee SK, et al. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release 2009;137:196.
- Park MR, Chun C, Ahn SW, et al. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel. J Control Release 2010;147:359.
- Cheng K, Blusztajn A, Shen D, et al. Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials 2012;33:5317.
- Langer R. New methods of drug delivery. Science 1990;249:1527.
- Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37.
- Wang H, Wei J, Yang C, et al. The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol. Biomaterials 2012;33:5848.
- Naderi-Meshkin H, Andreas K, Matin MM, et al. Chitosan-based injectable hydrogel as a promising in situ forming scaffold for cartilage tissue engineering. Cell Biol Int 2014;38:72.
- Chen G, Hoffman AS. Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH. Nature 1995;373:49.
- Alexander A, Ajazuddin Khan J, Saraf S, Saraf S. Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications. J Control Release 2013;172:715.
- Exner AA, Krupka TM, Scherrer K, Teets JM. Enhancement of carboplatin toxicity by Pluronic block copolymers. J Control Release 2005;106:188.
- Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004;58:445.
- Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997;388:860.
- Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 2000;33:94.
- Leong KW, Brott BC, Langer R. Bioerodible polyanhydrides as drug-carrier matrices. I: characterization, degradation, and release characteristics. J Biomed Mater Res 1985;19:941.
- Men K, Liu W, Li L, et al. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale 2012;4:6425.
- Ding D, Zhu ZS, Li RT, et al. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. ACS Nano 2011;5:2520.
- Gong CY, Wang C, Wang YJ, et al. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale 2012;4:3095.
- Liang Y, Xiao L, Li Y, et al. Poly(ester anhydride)/mPEG amphiphilic block copolymer nanoparticles as delivery devices for paclitaxel. J Biomater Sci Polym Ed 2011;22:701.
- Liang Y, Qiao Y, Guo S, et al. Thermoreversible gelation of poly(ethylene glycol)/poly(esteranhydride) triblock copolymer nanoparticles for injectable drug delivery systems. Soft Matter 2010;6:1915.
- Dong Y, Feng SS. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials 2007;28:4154.
- Yu DH, Lu Q, Xie J, et al. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials 2010;31:2278.
- Yang Y, Wang J, Zhang X, et al. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Release 2009;135:175.
- Bae SJ, Suh JM, Sohn YS, et al. Thermogelling poly(caprolactone-b-ethylene glycol-b-caprolactone) aqueous solutions. Macromolecules 2005;38:5260.
- Hwang MJ, Suh JM, Bae YH, et al. Caprolactonic poloxamer analog: PEG-PCL-PEG. Biomacromolecules 2005;6:885.
- Lee J, Joo MK, Oh H, et al. Injectable gel: poly(ethylene glycol)–sebacic acid polyester. Polymer 2006;47:3760.
- Jeong B, Choi YK, Bae YH, et al. New biodegradable polymers for injectable drug delivery systems. J Control Release 1999;62:109.
- Chuan X, Song Q, Lin J, et al. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)−drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Mol Pharm 2014;11:3656.
- Wang W, Deng L, Xu S, et al. A reconstituted “two into one” thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel. J Mater Chem B 2013;1:552.